City

Calgary (1)

Dallas (1)

Overall Status

Recruiting (2)

Sign in for free

Phase

phase 2/phase 3 (1)

Sponsor

University of Calgary (1)

University of Texas Southwestern Medical Center (1)

Collaborator

Allergan (1)

Massachusetts General Hospital (1)

Intervention

botulinum toxin type a (1)

magnetic resonance imaging (1)

placebo (1)

Study Documents

Intervention Type

drug (1)

other (1)

Funder Type

Other (2)

Study Type

Interventional (1)

Observational (1)

dystonia disorder

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Dystonia Genotype-Phenotype Correlation

Recruiting

Dystonia
+21 more

Magnetic Resonance Imaging

Dallas, Texas

University of Texas Southwestern Medical Center

Jun 30, 2022

Dystonia Disorder, Parkinson Disease Trial in Calgary (Botulinum toxin type A, Placebo)

Recruiting

Dystonia Disorder
Parkinson Disease

Botulinum toxin type A
Placebo

Calgary, Alberta, Canada

Movement Disorder Program, Foothills Medical Center, Alberta Hea

Nov 2, 2020